1. Home
  2. LFUS vs RGEN Comparison

LFUS vs RGEN Comparison

Compare LFUS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFUS
  • RGEN
  • Stock Information
  • Founded
  • LFUS 1927
  • RGEN 1981
  • Country
  • LFUS United States
  • RGEN United States
  • Employees
  • LFUS N/A
  • RGEN N/A
  • Industry
  • LFUS Electrical Products
  • RGEN Medical/Dental Instruments
  • Sector
  • LFUS Energy
  • RGEN Health Care
  • Exchange
  • LFUS Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • LFUS 6.3B
  • RGEN 7.6B
  • IPO Year
  • LFUS N/A
  • RGEN N/A
  • Fundamental
  • Price
  • LFUS $241.09
  • RGEN $124.73
  • Analyst Decision
  • LFUS Buy
  • RGEN Buy
  • Analyst Count
  • LFUS 5
  • RGEN 11
  • Target Price
  • LFUS $278.75
  • RGEN $190.25
  • AVG Volume (30 Days)
  • LFUS 107.5K
  • RGEN 662.3K
  • Earning Date
  • LFUS 10-29-2024
  • RGEN 11-12-2024
  • Dividend Yield
  • LFUS 1.16%
  • RGEN N/A
  • EPS Growth
  • LFUS N/A
  • RGEN N/A
  • EPS
  • LFUS 7.78
  • RGEN N/A
  • Revenue
  • LFUS $2,195,070,000.00
  • RGEN $639,915,000.00
  • Revenue This Year
  • LFUS N/A
  • RGEN $0.44
  • Revenue Next Year
  • LFUS $4.76
  • RGEN $12.13
  • P/E Ratio
  • LFUS $30.99
  • RGEN N/A
  • Revenue Growth
  • LFUS N/A
  • RGEN N/A
  • 52 Week Low
  • LFUS $222.91
  • RGEN $113.50
  • 52 Week High
  • LFUS $275.58
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • LFUS 36.55
  • RGEN 36.21
  • Support Level
  • LFUS $256.28
  • RGEN $137.27
  • Resistance Level
  • LFUS $263.04
  • RGEN $154.48
  • Average True Range (ATR)
  • LFUS 5.74
  • RGEN 7.09
  • MACD
  • LFUS -0.81
  • RGEN -0.55
  • Stochastic Oscillator
  • LFUS 0.81
  • RGEN 9.74

About LFUS Littelfuse Inc.

Littelfuse is a primary provider of circuit protection products (such as fuses and relays) into the transportation, industrial, telecommunications, and consumer electronics end markets. The firm is also increasing its power semiconductor business, where it predominantly serves industrial end markets and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: